以接觸式二極體雷射經鞏膜睫狀體光凝同術治療頑抗性青光眼

Contact Diode Laser Transscleral Cyclophotocoagulation (TSCP) for Refractory Glaucoma

林彥君(Yen-Chun Lin) ； 張雪麗(Shirley H. L. Chang) ； 吳秀琛(Shiu-Chen Wu) ； 許慶堂(Ching-Tarng Hsu)

《中華民國眼科醫學會雜誌》 39卷3期 (2000/09) Pp. 257-262

https://doi.org/10.30048/ACTASOS.200009.0006

摘要

目的：評估以接觸式二極體雷射經鞏膜睫狀體光凝固術治療頑抗性青光眼之安全性及有效性
方法：回溯性統計1997年8月至1998年7月期間54例56眼頑抗性青光眼接受G-probe治療之成效。
結果：每一眼燒灼點數平均為27點，範圍大部分為360度，功率2瓦，時間2秒，在平均治療5個月後，平均眼壓由術前的38.58mmHg下降至術後最後一次回診為20.02mmHg。症狀緩解者有48.12%，而青光眼用藥也呈現有意義的減少，自1.96種減少為0.85種。在併發症方面，有7眼前房出血，9眼眼壓過低，1眼眼球萎縮。
結論：本篇顯示以接觸式二極體雷射經鞏膜睫狀體光凝固術治療頑抗性青光眼在短期及中期為一安全有效的方法，然而更長期的療效仍持進一步的追蹤。

並列摘要

To analyze the effectiveness and safety of diode laser TSCP in the treatment of refractory glaucoma, we retrospectively reviewed 56 eyes of 54 patients who had received this treatment by either of 2 operators from August 1997 to July 1998. The mean number of spots was 27, most of treatment ranges were 360°, energy: 2Watts and duration: 2 seconds. After mean follow up time of 5 months, intraocular pressure was reduced from38.58mmHg to 20.02 mmHg, successful rate was 80.36% (defined as IOP reductionш≥20%). About half of the patients got symptom relief, and the medicine needed was also reduced significantly. Few complications were noted, which included hyphema in 7 eyes, hypotony in 9 eyes, and phthisis in 1 eye. This study revealed that diode laser TSCP is effective and safe in the treatment of refractory glaucom in short and mediun term, but long term follow up for further evaluation is needed.

並列關鍵字

glaucoma ； diode laser ； cyclodestructive procedure ； cyclophotocoagulation